Molecular mechanisms of Zika virus teratogenesis from animal studies : a systematic review protocol by Wachholz, Gabriela Elis et al.
PROTOCOL Open Access
Molecular mechanisms of Zika virus
teratogenesis from animal studies: a
systematic review protocol
Gabriela Elis Wachholz1,2,3†, Julia do Amaral Gomes1,2,3†, Juliano André Boquett1,4, Fernanda Sales Luiz Vianna1,2,3,5,
Lavínia Schuler-Faccini1,2,4 and Lucas Rosa Fraga2,3,5,6*
Abstract
Background: Due to the diversity of studies in animal models reporting that molecular mechanisms are involved in
the teratogenic effect of the Zika virus (ZIKV), the objective of the present study is to evaluate the methodological
quality of these studies, as well as to demonstrate which genes and which molecular pathways are affected by ZIKV
in different animal models.
Methods: This search will be performed in four databases: PubMed/MEDLINE, EMBASE, Web of Science, and
Scopus, as well as in the grey literature. The studies selection process will be reported through the PRISMA
Statement diagram model. All studies describing the molecular mechanisms possibly involved in the development
of malformations caused by embryonic/fetal ZIKV exposure in animal models with an appropriate control group
and methodology will be included (including, for instance, randomized and non-randomized studies). All animals
used as experimental models for ZIKV teratogenesis may be included as long as exposure to the virus occurred
during the embryonic/fetal period. From the selected studies, data will be extracted using a previously prepared
standard form. Bias risk evaluation will be conducted following the SYRCLE’s Risk of Bias tool. All data obtained will
be tabulated and organized by outcomes (morphological and molecular).
Discussion: With the proposed systematic review, we expect to present results about the methodological quality
of the published studies with animal models that investigated the molecular mechanisms involved in the
teratogenic effect of ZIKV, as well as to show the studies with greater reliability.
Systematic review registration: PROSPERO CRD42019157316
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Background
Zika virus (ZIKV) was first isolated from rhesus monkeys
in the Zika Forest (Uganda) in 1947, and the first cases of
human infection were reported in Nigeria in 1954 [6, 12].
In 2015, a large increase of newborns with microcephaly
was reported in Brazil [13], and it is already consolidated
by the literature that this increase was due to the exposure
to ZIKV infection during pregnancy [13, 18, 19].
The most concerning effects of ZIKV infection are related
to pregnancy, when its infection can lead to a set of abnor-
malities related to impaired Central Nervous System devel-
opment of the embryo/fetus. The phenotype spectrum
ranges from absent/mild/moderate microcephaly without
distinctive dysmorphic features to a severe microcephaly,
and also can include contractures, ranging from dimples to
generalized arthrogryposis [5]. Such abnormalities comprise
the Congenital ZIKV Syndrome (CZS) [4, 5].
Several experimental studies have presented results
that not only confirm ZIKV as the causative agent of the
observed congenital anomalies, but also suggest possible
molecular mechanisms by which the virus leads to ad-
verse outcomes. These animal studies include non-
human primates, chicken embryos, hamsters, guinea
pigs, and swine [3, 10, 14, 17, 23, 24], using different ap-
proaches to analyze the mechanisms of infection and
teratogenesis of ZIKV. Such results are related to ZIKV
changes in gene expression in genes involved in autoph-
agy and apoptosis processes in mouse embryos’ brains
[2] as well as cell cycle and immune response [11].
Little is known about how ZIKV can actually produce
the visualized changes in affected babies. In vivo studies
have pointed out the different pathways and genes or
proteins that are involved in this process; however, there
are few literature reviews on this field and no systematic
reviews. Thus, to compile, the results from experimental
models are important not only to understand the mo-
lecular mechanism of the syndrome, but also to propose
hypotheses, prevention strategies, and possible treatment
to the damage caused by the virus.
Objective
The objective of this systematic review is to assess the meth-
odological quality of the studies in animal models that inves-
tigated the molecular mechanisms of ZIKV teratogenesis.
Through a systematic search in literature databases and
proper data extraction and analyses, in addition to the evalu-
ation of the methodological quality of the studies, we aim to
present the genes and molecular pathways which were
shown to be affected by ZIKV in different animals.
Methods/design
Study question
This systematic review protocol has the following re-
search question: what are the molecular mechanisms
involved in the teratogenesis of the Zika virus proposed
in studies with animal models?
Protocol and registration
This protocol was developed by the members of the Re-
productive and Developmental Biology Laboratory at
Universidade Federal do Rio Grande do Sul. These
members are biologists and physicians specializing in
clinical, molecular and experimental teratogenesis. This
protocol was written in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-
Analysis Protocols (PRISMA-P) guideline [15, 20]. In
addition, the protocol has been registered with the Inter-
national Prospective Registry of Systematic Reviews




From the question proposed in this protocol, the study’s
Population, Intervention, Comparison, and Outcome
(PICO) was established, as well as its resulting concepts:
Population
The population/species studied will be animal models
with Congenital Zika Syndrome, including all species
already studied in all different types of biomedical and
biological experimental studies regardless of gender or
species.
Intervention
The intervention/exposure will be the exposure to ZIKV
during the embryonic/fetal period of development in any
method of exposure, in any viral amount/titration, and
at any stage of the embryo/fetal development.
Comparison
The control population will be given by a group of ani-
mals in the same study which undergone the same con-
ditions of the treated/exposed animals but without ZIKV
or other virus exposures.
Outcome
Two outcomes will be assessed. A primary outcome is
that the studies must be analyzing the occurrence of
congenital anomalies in the ZIKV-treated animals, where
at least one morphological parameter (anatomical, histo-
logical, etc.) proves such effects. A secondary outcome is
that all studies must have analyzed the presence or ab-
sence of molecular changes caused by such exposure
that may be correlated to the observed anomalies. These
molecular parameters include gene expression, proteo-
mics, methylation patterns, or any other approach that
investigates the possible changes in the patterns,
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structure, or amount of cellular macromolecules (DNA,
RNA and proteins).
Search strategy
A literature search to find relevant studies will be per-
formed in four databases: PubMed/MEDLINE, EMBASE,
Web of Science and Scopus, as well as in the grey litera-
ture, through the following sources: bioRxiv, OpenGrey,
and PQDT Open. The databases present publications
from medical, biomedical, pharmacological and life sci-
ences journal literature. Before starting this protocol,
searches were performed in order to identify any existing
systematic review of molecular mechanisms of ZIKV
from animal studies.
A combination of controlled vocabulary terms [e.g.,
Medical Subject Headings (MeSH)] and free-text terms
will be used in the searches. For instance, in PubMed/
MEDLINE search for ZIKV, the following will be used:
Zika Virus[mh] OR Zika Virus Infection[mh] OR NS1
protein, zika virus[nm] OR Zika[tiab] OR ZikV[tiab].
Drafts for the search strategies for all the four databases
that will be used for the systematic review are provided
in Supplementary Table 1. This list was developed by all
the members of the research group after consulting a li-
brarian with extensive experience in setting up search
strategies for systematic reviews of the Universidade
Federal do Rio Grande do Sul. No language restrictions
or publication date will be applied.
Study selection
Abstracts, conference papers, erratum, letters to the edi-
tor, and short survey will be considered for the system-
atic review. Review articles; editorials; case reports;
studies with humans or human samples; studies exclu-
sively ex vivo, in vitro, or in silico; studies in which
methodological information is absent or unclear; and
studies that have no relevance to the research question
will be excluded. In addition, vaccine development stud-
ies will also be excluded. Studies in which the exposure
to ZIKV has occurred in the postnatal period will not be
considered.
The process from searching for studies to the final se-
lection of studies that will compose the systematic re-
view is shown in Fig. 1. The selection of the relevant
studies will be performed in two phases. In the first
phase, two independent reviewers will screen by reading
Fig. 1 Flow chart showing the search and screening strategy to identify publications eligible for investigating the molecular mechanism of ZIKV
teratogenesis from animal studies
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the titles and abstracts of the articles. In the second
phase, full texts of the articles selected in the first phase
will undergo an evaluation. The study selection process
will be reported through the PRISMA Statement diagram
model (Fig. 1) [15, 20]. Two reviewers will screen all the
titles, abstracts, and full texts for potential eligibility in
an independent manner. Disagreements between re-
viewers will be resolved either by consensus or by con-
sulting a third reviewer. In addition, the evaluation of
agreement between reviewers will be tested by using
Cohen’s kappa coefficient test [1].
A pilot search using the designed search strategies
(Supplementary Table 1) was carried out on August 17,
2020, in which 1481 records were obtained (634 from
PubMed, 674 from EMBASE, and 173 records from
other sources). After the removal of duplicates (n =
177), 1304 unique studies were eligible for the title and
abstract screening. From this first screening, 38 publica-
tions were selected for full-text screening and seven
were finally selected for data extraction. Therefore, we
expect to include around 10–15 studies in the final sys-
tematic review.
Data extraction
General characteristics of the included articles
The data processing will be performed according to the
diagram presented in Fig. 2. The design and methodo-
logical characteristics of each study will be extracted
(Supplementary Table 2), such characteristics include
type of study, sample size of each experimental group,
experimental design (e.g., sample size calculation), ex-
perimental groups, animal housing, period of follow-up,
age of development in which animals were inoculated,
methods and techniques used for outcome assessment,
and use of guidelines to conduct and publish the study
(e.g., ARRIVE Statement) [9]. Information of animal
models will also be extracted, including species used,
lineage, age, and genetic modification factors.
Intervention characteristics
The method of ZIKV applications can be different
among species; in some species, the teratogenic agent is
applied directly onto the embryo (e.g., chicken embryos);
in others, the application is applied indirectly through
application to the mother (e.g., rodents and non-human
primates). Therefore, the methods of viral application/
embryonic exposure to ZIKV will also be extracted in
detail in order to compare the different studies (Supple-
mentary Table 2). Moreover, the amount of virus applied
(volume and viral load) and the route of viral inoculation
will also be extracted. Finally, the period in which ani-
mals have been exposed to ZIKV (post-inoculation time)
will also be assessed individually.
Outcome measures
Information regarding outcome data, their units, and
types will be collected according to the following
outcomes:
1. Teratogenic analyses data: number and percentage
of animals with congenital anomalies, descriptive
summary of such anomalies, and description of
organs (e.g., head and eyes) that showed differences
in morphological measurements between ZIKV-
exposed and controls. Since some studies have
shown variability between the confirmation of infec-
tion in the mothers and the embryos/fetuses (using
qPCR data), the number of animals with positive re-
sults to ZIKV infection will also be collected.
2. Molecular analyses data: the absence or presence, as
well as the measurements, of altered gene
expression, protein expression, epigenetic
characteristics of the location of a given protein in a
cell considering the experimental groups (case or
controls). In addition to these descriptive data,
information related to histological and cellular data
will be collected. Molecular data will have their
descriptive data collected (increase, decrease, or
absence of variation) as well as continuous data
(increase or reduction ratio, or absence of
variation).
These data will be extracted from both the original ar-
ticles and supplementary materials, when available or
even will be requested to the authors.
Initially, data extraction will be performed by obtain-
ing numerical and descriptive values directly from the
tables, figures, and information of the results section of
each study. When only percentages are presented, the
values will be calculated based on the sample size infor-
mation. Finally, if it is not possible to obtain relevant
data, the authors will be contacted.
In cases where two research sources are potentially de-
scribing the same data, the study with a larger dataset
and/or more complete reporting of the results will be in-
cluded. Data collection will be conducted by one re-
viewer and checked by a second. Cases of disagreement
will be resolved by consensus or by consultation of a
third reviewer.
Others parameters
The number of deaths, dropouts (animals that have been re-
moved from the study during the experiments), reason for
exclusion, and incomplete experiments will be extracted.
Assessment of risk of bias and study quality
Risk of bias and analysis of the quality of the studies will
be carried out independently by two reviewers of this
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study. Disagreement between the review authors will be
solved by including a third reviewer.
The risk of bias will be performed using the Sys-
tematic Review Center for Laboratory Animal Experi-
mentation (SYRCLE) Risk of Bias tool developed by
SYRCLE to assess animal intervention studies [8].
This tool includes domains of selection bias, driving,
detection, friction, and reporting of results. The risk
of bias from each study will be reported as low, un-
clear, and high. In addition to these types of biases
evaluated, we will include in the analysis peer-
reviewed publication, report on sample size calcula-
tion, and report on the use of guidelines for the exe-
cution and publication of the studies.
Fig. 2 Flow chart and data processing diagram for the proposed systematic review. RoB: risk of bias
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Data synthesis
From the pilot searches, it was possible to observe that
there is a high variability on the selected studies con-
cerning the methods of molecular evaluation (RNAseq,
qPCR, and so on), gestational period of intervention,
species evaluated, etc. Therefore, a meta-analysis involv-
ing studies with such different characteristics is unlikely
ever to be feasible. Therefore, data synthesis will be per-
formed in a narrative manner, as follows.
All data obtained will be tabulated and organized by
outcomes (morphological and molecular) in order to
allow further analysis. The studies will also be grouped
according to the used animal species for the in vivo as-
says, and, within the species groups, they will be differ-
entiated in lineages and ages of embryonic/fetal
development (by intervals) as well as the evaluated or-
gans in which the molecular analyses (RT-qPCR or RNA
sequencing, for example) were performed.
Morphological data will be combined and compared in
a descriptive manner according to the different studies,
since the focus of this review is on molecular alterations
and all included studies will be those that determine
structural malformations (congenital anomalies) in ex-
posed embryos. For molecular data, a list of genes/pro-
teins with altered expression or altered epigenetic
patterns will be created according to the abovemen-
tioned grouping method. Considering that the method
of evaluating these changes may have been conducted
with different tools and equipment, when possible, the
data will be pooled together aiming to find the most fre-
quently affected genes/proteins. All data will be ex-
tracted from groups exposed to ZIKV and controls, and
genes will be evaluated individually. Genes and proteins
will be compared and ranked according to the fold
change values.
The studies/data showing morphological and molecu-
lar alterations caused by ZIKV exposure during embry-
onic development will be prioritized for summary and
synthesis. Extracted data will be first presented narra-
tively in tables (morphological and molecular data ta-
bles) and then, whether possible, though Venn diagrams
and illustrations showing common genes/proteins af-
fected by the viral exposure.
The limitations of the data synthesis of the selected
studies are related to the fact that the research question
of this systematic review can generate diversified studies.
For instance, the studies can utilize different animal spe-
cies and different molecular analysis techniques, making
their combination difficult.
Availability of data
The complete list of studies will be made available as
supplementary material, and raw data will be made
available from the corresponding author on reasonable
request.
Discussion
We are conducting the first systematic review of possible
molecular mechanisms involved in CZS in animal
models. Nowadays, there are many studies comprising
ZIKV teratogenic capacities utilizing different animal
models as mice, rats, porcine, marmoset, chicken, and
non-human primates [2, 3, 7, 16, 17, 21, 22, 24]. Such
animal models are mainly used due to rodents being
very common to biomedical research or, in case of non-
human primates, due to their similarity to humans.
By compiling and comparing the data, the methodo-
logical quality of different studies on animal models will
be presented. From our systematic review, other studies
analyzing data in which no congenital defect was found
in animals exposed to ZIKV infection during develop-
ment would be interesting and helpful in explaining how
slight molecular changes could explain a threshold for
congenital anomalies. In this context, our results will
certainly be of great relevance for future studies in this
area, allowing the extrapolation of our findings in re-
search with hypotheses directed to humans or even ani-
mal models.
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